Multi-site Study of a Fully Automated AI Solution for HER2 Scoring in Breast Cancer

At the ESMO Breast Conference, Ibex presents a clinical poster that demonstrates how AI support showed improvements in HER2 scoring consistency, without compromising accuracy overall and for the analyzed clinical cut-offs. This study was a multi-site european country ranging 4 sites.

Share this article:

Subscribe to our newsletter:

By providing my details I agree that my data will be handled in accordance with IBEX Privacy Policy.

How is artificial intelligence rising to the challenge in breast cancer diagnosis?
How ‘game-changing’ AI is helping discover cancer for the first time in UK | ITV News
The AI revolution in cancer diagnostics with Joseph Mossel, CEO of Ibex Medical Analytics
Scroll to Top
IBEX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.